CURLF (Curaleaf Holdings) YoY EBITDA Growth: -24.50% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CURLF Curaleaf Holdings Inc CURLF
72 GF Score
Price $9.53
GF Value $8.04
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Curaleaf Holdings YoY EBITDA Growth?

Curaleaf Holdings CURLF +3.14% 72 YoY EBITDA Growth is -24.50% as of Mar. 2026. GuruFocus rates CURLF with a GF Score™ of 72/100 and a GF Value™ of $8.04 (Modestly Overvalued). The stock has 5 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Curaleaf Holdings's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was -24.50%.

Curaleaf Holdings's EBITDA per Share for the three months ended in Mar. 2026 was $0.19.

Curaleaf Holdings YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Curaleaf Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curaleaf Holdings YoY EBITDA Growth Chart

Curaleaf Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.47 -40.62 9.87 20.92 -3.50

Curaleaf Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.54 -5.00 -24.65 107.96 -24.50
CURLF
72GF Score
Curaleaf Holdings Inc CURLF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curaleaf Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Curaleaf Holdings's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.909-0.942)/ | 0.942 |
=-3.50 %

Curaleaf Holdings's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(0.188-0.249)/ | 0.249 |
=-24.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -24.50% mean?
Curaleaf Holdings (CURLF) has a YoY EBITDA Growth of -24.50% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Curaleaf Holdings and its competitors.
Is Curaleaf Holdings' YoY EBITDA Growth too high?
Curaleaf Holdings' current YoY EBITDA Growth is -24.50%. Overall, Curaleaf Holdings has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Curaleaf Holdings' YoY EBITDA Growth compare to ZTS and UTHR?
Curaleaf Holdings' YoY EBITDA Growth of -24.50% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Drug Manufacturers company?
A good YoY EBITDA Growth depends on the Drug Manufacturers industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Curaleaf Holdings and its competitors. Curaleaf Holdings's current YoY EBITDA Growth is -24.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curaleaf Holdings stock overvalued right now?
Based on GuruFocus' analysis, Curaleaf Holdings (CURLF) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.04, compared to a current price of $9.53 — trading 18.5% above its estimated fair value. The current YoY EBITDA Growth is -24.50%. Curaleaf Holdings' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Curaleaf Holdings (CURLF), the current YoY EBITDA Growth is -24.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Curaleaf Holdings (CURLF) Overvalued in 2026?

Based on GuruFocus' analysis, Curaleaf Holdings stock appears to be overvalued. The current stock price of $9.53 is trading 18.5% above its estimated GF Value™ of $8.04. GuruFocus considers Curaleaf Holdings to be Modestly Overvalued.

Key valuation signals for CURLF:

  • YoY EBITDA Growth: -24.50%
  • GF Value™: $8.04 vs. price of $9.53 (18.5% above fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the CURLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Curaleaf Holdings Business Description

Other Exchanges 2XW:GermanyCURA:Canada
Address 290 Harbor Drive, Stamford, CT, USA, 06902
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
72GF Score

Get the complete analysis for CURLF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.53
Price
$8.04
GF Value